Zum Inhalt
NEU: Events vieler Veranstalter direkt auf R4F buchen. Bequem und einfach. Jetzt buchen

123707 Link

In the quiet labs of the California Department of Public Health, a specialized team works under a unique legal mandate to solve a terrifying medical mystery: infant botulism. While rare, this condition can paralyze an infant’s muscles, making it impossible for them to breathe or eat.

Governed by California Health and Safety Code § 123707 , the Infant Botulism Treatment and Prevention Unit isn't just a regulatory body—it’s a manufacturer. It is the primary entity authorized to handle the distribution and licensure of Botulism Immune Globulin Intravenous (Human) , often referred to by its trade name, BabyBIG®. 123707

: To ensure rapid response, the department is exempt from standard competitive bidding for the testing and distribution of the treatment. In the quiet labs of the California Department

The number refers to California Health and Safety Code § 123707 , which governs the Infant Botulism Treatment and Prevention Unit . This unit is responsible for the manufacture, distribution, and licensure of Botulism Immune Globulin Intravenous (Human) , a life-saving treatment for infants. It is the primary entity authorized to handle

AI responses may include mistakes. For legal advice, consult a professional. Learn more California Code, Health and Safety Code - HSC § 123707

Below is a feature article written about this unit and its critical mission.

The Sentinel of the Cradle: Inside California’s Lifesaving Botulism Unit